NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"), of the important October 5, 2026 lead plaintiff...
Hence then, the article about ars pharmaceuticals deadline spry investors have opportunity to lead ars pharmaceuticals inc securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- Oatly Is Dropping Three New Flavors for Fall
- TVLine Asks: Did DWTS Elimination Devastate? Was Ted Lasso's Siri Plug A Bit Much? Did Scrubs Sneak In A Shrinking Reference? And More
- Shivon Zilis Shares Elon Musk’s Last Text and Calls Him a ‘Tortured Soul’ After Sudden Breakup